Net Profit Margin
since 2005
Difficulty: Beginner
Calculation
Merck & Co. Inc., net profit margin, long-term trends, calculation
| Net Profit Margin | = | 100 | × | Net income attributable to Merck & Co., Inc.1 | ÷ | Sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | 21.04% | = | 100 | × | 4,631 | ÷ | 22,012 |
| Dec 31, 2006 | 19.59% | = | 100 | × | 4,434 | ÷ | 22,636 |
| Dec 31, 2007 | 13.54% | = | 100 | × | 3,275 | ÷ | 24,198 |
| Dec 31, 2008 | 32.74% | = | 100 | × | 7,808 | ÷ | 23,850 |
| Dec 31, 2009 | 47.04% | = | 100 | × | 12,901 | ÷ | 27,428 |
| Dec 31, 2010 | 1.87% | = | 100 | × | 861 | ÷ | 45,987 |
| Dec 31, 2011 | 13.05% | = | 100 | × | 6,272 | ÷ | 48,047 |
| Dec 31, 2012 | 13.05% | = | 100 | × | 6,168 | ÷ | 47,267 |
| Dec 31, 2013 | 10.00% | = | 100 | × | 4,404 | ÷ | 44,033 |
| Dec 31, 2014 | 28.22% | = | 100 | × | 11,920 | ÷ | 42,237 |
| Dec 31, 2015 | 11.25% | = | 100 | × | 4,442 | ÷ | 39,498 |
| Dec 31, 2016 | 9.85% | = | 100 | × | 3,920 | ÷ | 39,807 |
| Dec 31, 2017 | 5.97% | = | 100 | × | 2,394 | ÷ | 40,122 |
1 USD $ in millions
Source: Based on data from Merck & Co. Inc. Annual Reports
Comparison to Competitors
Merck & Co. Inc., net profit margin, long-term trends, comparison to competitors
| Merck & Co. Inc. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Celgene Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | 21.04% | 15.10% | –% | 8.40% | 30.56% | 6.63% | 15.62% | 14.28% | 13.52% | 44.99% | 20.61% | 15.76% | -144.19% |
| Dec 31, 2006 | 19.59% | 7.64% | –% | -22.48% | 21.29% | 8.11% | 8.85% | 8.50% | 16.97% | -45.98% | 20.73% | 39.98% | -161.30% |
| Dec 31, 2007 | 13.54% | 13.92% | –% | 5.65% | 22.12% | 20.12% | 11.19% | 17.41% | 15.85% | 43.27% | 17.31% | 16.82% | -84.46% |
| Dec 31, 2008 | 32.74% | 16.53% | –% | 9.40% | 28.57% | 19.11% | 25.47% | -71.74% | -10.17% | 39.55% | 20.31% | 16.78% | -34.69% |
| Dec 31, 2009 | 47.04% | 18.68% | –% | 7.95% | 32.09% | 22.16% | 56.42% | 30.25% | 19.82% | 40.74% | 19.82% | 17.27% | -17.88% |
| Dec 31, 2010 | 1.87% | 13.15% | –% | 5.17% | 31.56% | 21.31% | 15.92% | 25.10% | 21.97% | 39.26% | 21.65% | 12.18% | -22.76% |
| Dec 31, 2011 | 13.05% | 12.17% | –% | 5.69% | 24.08% | 24.45% | 17.46% | 28.05% | 17.90% | 34.60% | 14.87% | 14.84% | -49.74% |
| Dec 31, 2012 | 13.05% | 14.95% | 28.70% | 1.64% | 26.11% | 25.02% | 11.12% | 27.04% | 18.09% | 27.57% | 16.14% | 24.70% | 54.43% |
| Dec 31, 2013 | 10.00% | 11.79% | 21.97% | -8.65% | 27.93% | 26.87% | 15.64% | 22.79% | 20.27% | 28.46% | 19.40% | 42.65% | 20.16% |
| Dec 31, 2014 | 28.22% | 11.28% | 8.89% | -12.48% | 26.69% | 30.25% | 12.62% | 26.44% | 12.19% | 49.44% | 21.96% | 18.42% | 12.34% |
| Dec 31, 2015 | 11.25% | 21.68% | 22.50% | 25.98% | 33.13% | 32.95% | 9.45% | 17.49% | 12.07% | 56.32% | 21.99% | 14.25% | 15.50% |
| Dec 31, 2016 | 9.85% | 6.71% | 23.22% | 102.76% | 35.27% | 32.34% | 22.94% | 17.87% | 12.90% | 45.07% | 23.01% | 13.66% | 18.42% |
| Dec 31, 2017 | 5.97% | 1.74% | 18.82% | -25.88% | 9.08% | 20.69% | 4.85% | 22.66% | -0.89% | 18.03% | 1.70% | 40.55% | 20.41% |
Source: Based on data from Merck & Co. Inc. Annual Reports
Comparison to Pharmaceuticals & Biotechnology Sector
Merck & Co. Inc., net profit margin, long-term trends, comparison to Pharmaceuticals & Biotechnology sector
| Merck & Co. Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2005 | 21.04% | 18.26% |
| Dec 31, 2006 | 19.59% | 20.89% |
| Dec 31, 2007 | 13.54% | 16.34% |
| Dec 31, 2008 | 32.74% | 18.08% |
| Dec 31, 2009 | 47.04% | 26.33% |
| Dec 31, 2010 | 1.87% | 15.57% |
| Dec 31, 2011 | 13.05% | 15.78% |
| Dec 31, 2012 | 13.05% | 18.82% |
| Dec 31, 2013 | 10.00% | 21.77% |
| Dec 31, 2014 | 28.22% | 20.93% |
| Dec 31, 2015 | 11.25% | 22.73% |
| Dec 31, 2016 | 9.85% | 24.60% |
| Dec 31, 2017 | 5.97% | 11.23% |
Source: Based on data from Merck & Co. Inc. Annual Reports
Comparison to Health Care Industry
Merck & Co. Inc., net profit margin, long-term trends, comparison to Health Care industry
| Merck & Co. Inc. | Health Care | |
|---|---|---|
| Dec 31, 2005 | 21.04% | 15.39% |
| Dec 31, 2006 | 19.59% | 16.20% |
| Dec 31, 2007 | 13.54% | 13.46% |
| Dec 31, 2008 | 32.74% | 13.75% |
| Dec 31, 2009 | 47.04% | 18.84% |
| Dec 31, 2010 | 1.87% | 12.17% |
| Dec 31, 2011 | 13.05% | 12.34% |
| Dec 31, 2012 | 13.05% | 13.00% |
| Dec 31, 2013 | 10.00% | 13.91% |
| Dec 31, 2014 | 28.22% | 13.46% |
| Dec 31, 2015 | 11.25% | 14.07% |
| Dec 31, 2016 | 9.85% | 14.91% |
| Dec 31, 2017 | 5.97% | 8.69% |
Source: Based on data from Merck & Co. Inc. Annual Reports